Supportive Care Project
The Supportive Care Project was launched in April 2020, taking over the project in the Division of Supportive Care Research at EPOC. Cancer supportive and palliative care to improve the quality of life (QOL) of cancer patients is important, but there is few analgesics that can deal with intractable pain for instance. There are many unmet medical needs that need to be resolved.
The Supportive Care Project selected projects that have been undertaken in the Division of Supportive Care Research at EPOC especially those that will bridge to and conduct joint research with pharmaceutical companies, and the projects will be carried out within 3 years.
- Development and development support for novel drugs for cancer patients with cachexia and patients with anticancer drug that possess cardiotoxicity
- Creation and clinical development of novel opioid preparations (μ/δ opioid dimerized receptor-specific agonists that cause less side effects)
- Establishment and implementation in detection system of biomarkers of delirium that predicts its onset, with analysis of bloods from patients undergoing long-term cancer surgery
In this project, among the seeds that are unmet medical needs for supportive and palliative care, we specialize the development of seeds that proceed to joint research with pharmaceutical companies. We will tie up these studies with the Support and Palliative Research and Development Support Office at National Cancer Center Hospital East to construct a Project Base for advancing clinical research specializing for supportive and palliative care.